THE TOKYO HEP CLINICAL FORUM IS COMING FOR THE FIRST TIME TO TOKYO ON 28-29 OCTOBER 2019!
New data on the treatment of Hepatitis infected individuals are being presented and published at a high rate. These data have the potential to impact optimal patient care, but it is a challenge for busy clinicians to stay informed about these rapid developments and thus to continue providing the best treatment available for their patients. To keep up-to-date with these latest developments, there is a need for an educational platform that effectively informs clinicians and other healthcare professionals of them in an efficient manner. In addition, clinicians need to be able to exchange their experiences and get the opportunity to discuss with experts in the field about how to optimally apply the latest insights on new drugs and new treatment strategies in their practice.
The Hepatitis Clinical Forum provides a state-of-the-art program with challenging plenary lectures followed by ample time for questions and interactions. In addition, the program includes clinical case presentations, in which the medical community shares their clinical experience by presenting and discussing real-life cases.
The TOKYO HEP CLINICAL FORUM is the first of a new series of interactive programs that provide independent medical education on emerging topics in Hepatitis. The program features international and regional experts in order to provide Hepatitis clinicians and allied healthcare professionals with updates on the latest developments related to Hepatitis management. The meeting provides a unique opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts / research programs.
Local Chair & Co-Chair
National Center for Global Health and Medicine/National Cancer Institute,
University of Tokyo,
Erasmus Medical Center,
Sheba Medical Center,
MONDAY 28 OCTOBER
10:00 Registration, Reception, Coffee
10:30 Introduction and Goals
Hiroaki Mitsuya, MD, PhD - National Center for Global Health and Medicine/National Cancer Institute,Japan/USA
10:40 Needs Assessment
Session 1 - Hepatitis/ liver diseases in Japan
Chairs: Kazuhiko Koike & Charles Boucher
10:45 Epidemological trends in viral Hepatitis B and C in Japan
Junko Tanaka, MD, PhD - Hiroshima University, Japan
11:10 Trend of NAFLD/ NASH in Japan
Katsutoshi Tokushige, MD - Tokyo Women’s Medical University, Japan
11:35 Trends in epidemiology of hepatitis B and HCC in Asia
Sang Hoon Ahn, MD, PhD - Yonsei University College of Medicine, South Korea
Session 2 - Clinical management of Hepatitis C
Chairs: Tesuo Takehara & Man-Fung Yuen
13:30 State-of-the-Art: Current clinical management of hepatitis C in Japan
Nobuyuki Enomoto, MD, PhD - University of Yamanashi, Japan
13:55 Hepatitis C management in special populations
Mark Nelson, MD - Chelsea And Westminster Hospital, United Kingdom
14:20 Challenges in the era of hepatitis C cure
Naoya Sakamoto, MD - Hokkaido University, Japan
14:45 HCV-associated HCC - Basics and clinics
Naoya Kato, MD, PhD - Chiba University, Japan
15:30 Coffee break
Session 3 - Clinical management of Hepatitis B
Chairs: Naoya Kato & Naoya Sakamoto
16:00 State-of-the-Art: Current clinical management of hepatitis in Japan
Hiroshi Yatsuhashi, MD - NHO Nagasaki Medical Center, Japan
16:25 Management of Hepatitis B reactivation
Yasuhito Tanaka, MD, PhD - Nagoya City University, Japan
16:50 Co-infection of HIV, HBV and HCV
Hiroyuki Gatanaga, MD, PhD - National Center For Global Health And Medicine, Japan
17:15 New anti-HBV drugs in the pipeline
Man-Fung Yuen, DSc, MD, PhD - University of Hong Kong, Hong Kong
18:00 End of Day 1
TUESDAY 29 OCTOBER
Session 4 - Hepatitis C elimination strategies
Chairs: Nobuyuki Enomoto & Peter Revill
9:00 Update on Hepatitis C elimination strategies
Margaret Hellard, MD - Burnet Institute, Australia
9:25 Immunological aspects of HBV and HCV infection
Tatsuya Kanto, MD, PhD - National Center for Global Health and Medicine, Japan
9:50 Current treatment of decompensated cirrhosis
Tetsuo Takehara, MD - Osaka University, Japan
10:30 Coffee break
Session 5 - Future clinical management of liver diseases
Chairs: Yasuhito Tanaka & Margaret Hellard
11:00 Progress in Hepatitis B cure research
Peter Revill, MD, PhD - Victorian Infectious Diseases Reference Laboratory, Australia
11:25 Current and future treamtments of NASH
Atsushi Nakajima, MD - Yokohama City University, Japan
11:50 Current and future local therapies for early stage HCC
Shi-Ming Lin, MD - Linkou Chang Gung Memorial Hospital, Taiwan
12:15 Evolving treatment paradigm and future landscape in HCC
Masafumi Ikeda, MD - National Cancer Center Hospital East, Japan
Registration is free of charge for all healthcare practitioners*. A registration fees applies to other individuals.
*Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with Hepatitis. If you are not sure, please do not hesitate to contact us at firstname.lastname@example.org.
Virology Education (VE), with generous support by Gilead Sciences is offering Scholarships for the Tokyo HEP Clinical Forum to HEP healthcare practitioners from the Asian region. (Please note: any applications from outside the Asian region will automatically be declined).
What the Scholarship covers
Registration to the meeting
Support for travel of up to EUR 600
Hotel accommodation for 2 nights on 27 and 28 October 2019
a) All arrangements will be made by Virology Education
b) Applicants must attend the entire Conference.
c) Applicants will be responsible for all other costs associated with Conference attendance.
d) Please see the Conference website for further details about the Conference.
What is expected from you:
Recipient will be onsite at the Conference, attend all sessions and participate actively for the duration of the Conference. Recipient must sign in to each session as requested by VE.
Recipient will provide a post-meeting feedback and summary about his/her Conference experience within 1 month after the end of the Conference. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the conference, Scholarship procedure and how they will implement the knowledge acquired at the meeting in their daily practice. The questionnaire will be send to each recipient by email within one week after the conclusion of the conference.
The applicant must be a healthcare practitioner.
The applicant must be from the Asian region.
The applicant must be willing to share his/her experience at the Conference within his network.
The applicant must be eligible to obtain a visa for travel.
The applicant must declare that she/he is able and willing to fund all other costs beyond the grant that are involved in attending the Conference, e.g. all other hotel, travel and subsistence expenses NOT covered by the Scholarship.
The applicant must declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the Conference).
Your application will include the following:
Your contact details (e.g. name and email address)
Motivation letter consisting of a written statement of up to 200 words, on
how attending the Conference will benefit you in a professional capacity
how you intend to apply the benefits that you have outlined in a practical way after the Conference
Recommendation letter(s) (optional)
A declaration that you agree with the terms & conditions for application
Your application must be received by Sunday 20 October
All applications will be acknowledged upon receipt.
All applications will be reviewed by an independent Scholarship Review Committee based on the following Grant Selection Criteria:
Strategy of knowledge dissemination
Recommendation by the Scientific and Organizing Committee of the meeting
Quality of the Abstract (if accepted)
Young/ Early Career Investigator
All applicants will receive notification of the application status no later than 25 October 2019.
Please submit your application through the Scholarship Application Portal on the Conference website.
We humbly request your support in encouraging healthcare professionals to apply by forwarding this information to your colleagues.
This program has been made possible by an unrestricted educational grant from Gilead Sciences
We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay in Tokyo.
Accommodation for grantees will be arranged at Akasaka Excel Hotel Tokyu.
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent by e-mail after the workshop.
Conference materials can be obtained upon registration at the registration desk at the conference venue starting 10:00 AM
on Monday 28 October.
The official conference language is English.
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
The meeting will be held at Imperial Hotel, located in the center of Tokyo.
Imperial Hotel Tokyo
1-1, Uchisaiwai-cho 1-chome, Chiyoda-ku
Free Wi-Fi will be available in the meeting room. Access codes will be made available on the first day of the meeting.
Payment and procedure of on-line registration
Registration is free of charge for all healthcare practitioners. Your registration will be confirmed as soon as possible. If you do not receive a confirmation within three days after your registration, please contact the organizing secretariat email: .
Photographs, audio and video recording
Photographs as well as audio and video recordings are not permitted at the official meeting sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
For any inquiries or questions, please contact Virology Education at email@example.com or call +31 (0)30 230 7140. You can also contact us by filling out the contact form.